Skip to main content

Table 2 Biomarker serum levels

From: Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study

 At-risk women without PEAt-risk women with PEp-value
Biomarker Levels
 GlyFn (μg/mL)233 (92)457 (206)< 0.001
 PAPPA2 (ng/mL)72 (130)505 (330)< 0.001
 PlGF (pg/mL)275 (308)40 (57)< 0.001
 sFlt-1 (ng/mL)2186 (2170)9869 (6613)< 0.001
  1. Data are displayed as median (IQR). Biomarker distributions are compared via Wilcoxon rank sum test
  2. GlyFn glycosylated fibronectin, PAPPA2 pregnancy-associated plasma protein-A2, PlGF placental growth factor, sFlt-1 soluble fms-like tyrosine kinase-1